EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Galectin-3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases

Luís Perpétuo iD

ACS Pharmacology & Translational Science · 10.04.2026 · 9 (4) · 771-783

DOI: 10.1021/acsptsci.5c00671 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 11.03.2026. Verfasst von Luís Perpétuo. Beteiligte Einrichtung: iBiMED, Department of Medical Sciences, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funda??o para a Ci?ncia e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkersclinical trialsgalectin-3heart failuremyocardial infarction

Autor:innen und Institutionen

  • iBiMED, Department of Medical Sciences, University of Aveiro, Campus Universitário de Santiago, Aveiro 3810-193, Portugal.
  • Cardiovascular R&D Centre - RISE-Health, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Alameda Professor Hernâni Monteiro, Porto 4200-319, Portugal.

ORCID-Profile: Luís Perpétuo

Förderung

  • Funda??o para a Ci?ncia e a Tecnologia

Zitieren

APA

Perpétuo, L. (2026). Exploring Galectin-3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases. ACS Pharmacology & Translational Science, 9(4), 771-783. https://doi.org/10.1021/acsptsci.5c00671

Vancouver

Perpétuo L. Exploring Galectin-3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases. ACS Pharmacology & Translational Science. 2026;9(4):771-783. doi:10.1021/acsptsci.5c00671

BibTeX
@article{Perptuo2026,
  author = {Perpétuo, Luís},
  title = {Exploring Galectin-3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {771--783},
  doi = {10.1021/acsptsci.5c00671}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche